Verteporfin photodynamic therapy for neovascular age-related ...

More documents

Recommendations

Info

166 Appendix 1Appendix 9:Site implementation and trainingBackgroundNearly a year’s experience with the three pilot installations (Liverpool: S Harding, L Gee;Wolverhampton, YC Yang; Newcastle: J Talks) has shown the benefit of a personalised onsiteapproach to training. In particular, it is now clear that the instructions on the use of thesoftware must be followed up immediately by practical use of the software in the ‘live’environment. This might be within the clinic itself, as practised in Liverpool, or after the clinicas in Wolverhampton or a mix of the two as in Newcastle.In either case, it is now certain that there is considerable value to be gained by supervisingthe use of the database software and correcting any mistakes or oversights in manipulationas they first arise. The return, in terms of the reduced need for on-line support and recovery,is considerable. With this in mind the following proposal has been drawn up.Commitment of the Participating UnitIt has proven difficult, with the pilot centres, to obtain a commitment of more than an hourfrom the ophthalmologists to receive training. This is understandable given the time pressureunder which most are operating.However, it is clear that adequate time must be spent with every person who will be enteringdata on the system, both clinical and nursing staff. This commitment must include time forinstruction and for the input of real locally generated data in addition to test data provided aspart of the course material. For each individual this will take between one and a half and twohours in total. Some of this time could include real data entry in the live clinic situation.Because of the importance of training in the continuance of the project, if any clinic is unableor refuses to commit to the necessary time to train, the software will not be installed at theirDP.Local Project Management TeamIn order to smoothly introduce the VPDT Cohort Study into any site, a local projectmanagement team will be established to include:Lead clinician(s)To advise on clinic set-up and implementationDirectorate manager or nominated deputyTo provide financial and trust authority, staff allocation, etcIT leadTo provide links with hardware purchasing and software installation, network issues,data transferData managerA full time post funded within the Cohort Study with responsibility for all data processesincluding data entry, error checking, queries and liaising with Strategen and LSHTMRepresentative from Strategen (John Fullarton, Scot Buchan, Mark Howland)Contact from VPDT Investigators / Data Management Centre (Usha Chakravarthy, SimonHarding, Barney Reeves, Sonia Dhiman, Julia Langham).Contact from Digital Healthcare (Rob Stitchbury, Simon Edwards)The Local Project Management Team should be established prior to site implementation andtraining with hardware and software issues resolved.
DOI: 10.3310/hta16060Health Technology Assessment 2012; Vol. 16: No. 6167Training CurriculumStage 1 – Basic Use of SoftwareStage 1 training must cover the following elements:Software ManipulationsFamiliarity with ACCESS – starting, main sections, closing down(For existing pilot centres: familiarisation with the new screen layouts)Sequence of data entry, nurse fields and clinician fieldsManipulation of fields, free text, drop down lists, mandatory fieldsSubsidiary window buttonsData display, scrolling keysShort cutsFinding PatientsUsing patient codes, understanding coding practiceUsing search windowScrolling recordsIdentifying the correct patientNew patients; existing patientsEntering Visit Data (using fictitious data)New patients, existing patientsStudy eye, non-study eye, new study eyeCorrecting data, deleting recordsSigning off, data qualitySending dataE-mail links and manipulationRecord lockingReportsStandard reportsBespoke reportsThese basic training elements will be supported by the User Guide, which will be left with theunit, and the Training manual, which will be used as guidance for the trainer.It is anticipated that Stage 1 of the training curriculum will take a half day for each DP on-siteand involve a further half day for Strategen in the preparation of course materials to ensuresmooth implementation on the day.Stage 2 - Practical Use of SoftwareThe second part of the training will involve the use of the software in entering real data. Mostconveniently this could happen on the same day as the training in a routine clinic later in theday. Alternatively it should take place within two or three days. In either case data-entry mustbe supervised by the trainer on-site.Option 1 – units intending to use live data capture in clinicThis is the ideal method of data collection but it is recognised that not all DPs will have thenecessary IT infrastructure to implement it.Data entry will be observed in the live clinic environment.The observations will ensure that:• Routine software manipulations are carried out correctly (as under Stage 1 above)• Data capture is accurate – compared to the clinic notes• Errors/potential errors of manipulation are caught and corrected© Queen’s Printer and Controller of HMSO 2012. This work was produced by Reeves et al. under the terms of a commissioning contract issued by theSecretary of State for Health.
Page 5 and 6:
DOI: 10.3310/hta16060Health Technol
Page 12 and 13:
xExecutive summaryretreat on criter
Page 14 and 15:
xiiExecutive summaryof data, with i
Page 16 and 17:
2 Introductionon-going or new clini
Page 18 and 19:
4 Introductionof VPDT in routine cl
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31:
Page 34 and 35:
20 Key changes to the protocolThese
Page 36 and 37:
22 Key changes to the protocolCentr
Page 38 and 39:
24 Key changes to the protocolADVER
Page 40 and 41:
26 Key changes to the protocolPlan
Page 42 and 43:
28 Key changes to the protocolClass
Page 44 and 45:
30 Key changes to the protocolFor i
Page 46 and 47:
32 Key changes to the protocolIn ad
Page 48 and 49:
34 Key changes to the protocolsites
Page 52 and 53:
38 Results (1) - study cohortTABLE
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
46 Results (2) - objectives A, B, C
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77:
Page 80 and 81:
66 Discussion of resultsStrengths a
Page 82 and 83:
68 Discussion of resultsThe VPDT st
Page 84 and 85:
70 Discussion of resultsOur analyse
Page 86 and 87:
72 Discussion of resultsA further c
Page 88 and 89:
74 Discussion of resultsVPDT. It is
Page 91 and 92:
Page 93 and 94:
Page 95:
Page 98 and 99:
84 References16. Stelmack J. Qualit
Page 100 and 101:
86 References49. Guymer RH, Chiu AW
Page 102 and 103:
88 References83. Margrain TH. Minim
Page 104 and 105:
90 Appendix 1THE VERTEPORFIN PHOTOD
Page 106 and 107:
92 Appendix 11. Overview of Manual
Page 108 and 109:
94 Appendix 1And, if also collectin
Page 110 and 111:
96 Appendix 1more patients in the v
Page 112 and 113:
98 Appendix 12.4 Limitations of the
Page 114 and 115:
100 Appendix 1Box 2 Key advantages
Page 116 and 117:
102 Appendix 14. Study population4.
Page 118 and 119:
104 Appendix 15. Recruitment to the
Page 120 and 121:
106 Appendix 16. Background data co
Page 122 and 123:
108 Appendix 1Table 1: Schedule of
Page 124 and 125:
110 Appendix 1The Verteporfin Photo
Page 126 and 127:
112 Appendix 1• Additional clinic
Page 128 and 129:
114 Appendix 18. Recording adverse
Page 130 and 131: 116 Appendix 1level of benefit from
Page 132 and 133: 118 Appendix 1• comparison of num
Page 134 and 135: 120 Appendix 110.6 Sub-group analys
Page 136 and 137: 122 Appendix 112. Data issues12.1 D
Page 138 and 139: 124 Appendix 113. Organisation13.1
Page 140 and 141: 126 Appendix 114. References[1] Ref
Page 142 and 143: 128 Appendix 1Barnes RM, Gee L, Tay
Page 144 and 145: 130 Appendix 1Appendix 1: Classifyi
Page 146 and 147: 132 Appendix 1Liverpool re-treatmen
Page 148 and 149: 134 Appendix 1Service StructurePlea
Page 150 and 151: 136 Appendix 1Has your photographer
Page 152 and 153: 138 Appendix 1There are many differ
Page 154 and 155: 140 Appendix 1testing on vision tes
Page 156 and 157: 142 Appendix 1something to do with
Page 158 and 159: 144 Appendix 1College of Ophthalmol
Page 160 and 161: 146 Appendix 1Appendix 5:Protocol f
Page 162 and 163: 148 Appendix 16.2 Subjective Refrac
Page 164 and 165: 150 Appendix 1• The patient shoul
Page 166 and 167: 152 Appendix 1Appendix 6:Protocol f
Page 168 and 169: 154 Appendix 18. It is customary to
Page 170 and 171: 156 Appendix 1Early or Transit Phas
Page 172 and 173: 158 Appendix 1
Page 174 and 175: 160 Appendix 1---------------------
Page 182 and 183: 168 Appendix 1Option 2 - units inte
Page 184 and 185: 170 Appendix 1Dos and Don’tsDosDo
Page 186 and 187: 172 Appendix 1Resource use question
Page 188 and 189: 174 Appendix 1Appendix 11: Recommen
Page 190 and 191: 176 Appendix 1ADVERSE REACTION AND
Page 192 and 193: 178 Appendix 1acute Trust; note tha
Page 194 and 195: 180 Appendix 1Ophthalmologistrespon
Page 197 and 198: DOI: 10.3310/hta16060Health Technol
Page 203: DOI: 10.3310/hta16060Health Technol
Page 206 and 207: 192 Appendix 3manufacturer’s pers
Page 216: FeedbackThe HTA programme and the a
show all

Verteporfin photodynamic therapy for neovascular age-related ...

Create successful ePaper yourself

Delete template?

Save as template?